... because "remember, September isn't over yet." And
... because "remember, September isn't over yet." And "funding is secured through the end of the year." And we should start injecting cancer patients "any day now".
Some of these things were probably NP's fault. Others were at least somewhat out of the company's hands. It doesn't matter. The baseline assumption for most is that publically-stated, self-imposed deadlines will be blown past with impunity. It's December 17th, and we don't even know if the FDA has opined on dosage. A BLA filing prior to 2020 would be a very pleasant surprise.
As to why they should theoretically PR it first and steal their own thunder... because that's how responsibly managed companies communicate significant events. Exposure - or lack thereof - is a key issue for the company. They should be doing everything possible to increase that exposure... like PR'ing major events and only then having a CC. I'd prefer that institutional investors and market watchers be given a reason to dial in to the CC and ask salient questions of management.
All of that said, I have no expectations that management would approach messaging properly at this point. Experience tells me that this is not a strong suit for the company, and I question their responsiveness to the various IR firms they've hired over the years since nothing seems to materially change in the approach, messaging, or outcomes with respect to exposure and the courting of institutional investors.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...
Continue Reading
Driving AI Adoption: A Shift Towards Human-Centric Learning McLean & Company has dropped an initiative that’s like laying fresh tracks for AI inclusion in businesses. Dubbed the Human-Centric AI Program, it’s a wake-up call to organizations struggling to shift AI from a novelty to a natural part of operations. This isn’t just about fiddling with AI tools; it’s...
Continue Reading
You ever get that sense of déjà vu when another company decides to jump ship from a supposedly hot market? Well, that's where Ecobat's at, folks. This global player in battery recycling just waved goodbye to its lithium recycling biz, closing the deal on its Arizona operations. Previously, they ditched similar holdings in the UK and Germany. Now, they're all-in on their...
Continue Reading
Unpacking the GoPro Buyout Announcement There's some commotion brewing in the investor world, especially if you're clutching onto shares of GoPro (NASDAQ:GPRO). A $1.14 per share buyout has hit the spotlight, and folks are asking if this deal is kosher, particularly when there's $285 million on the line. Does the price truly reflect what GoPro's worth? Ademi LLP is...
Continue Reading
MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...
Continue Reading
AI Expansion at EcoHash: A Strategic Stride Some days you wake up, read a company pushing its legacy into something new, and you just gotta wonder if they’ve hit paydirt or just blowing smoke. For Cango Inc. and its subsidiary EcoHash, this latest update is shaping up interesting. They're no small potatoes in mining Bitcoins, but they're now trying their hand at AI...
Continue Reading
A Looming Need for Home-based Care Take a long, deep breath and visualize this: by 2035, America's gonna need roughly 850,000 more home care workers. That's a head-spinning figure, and if you haven't been keeping up with the projections, let me fill you in on something the Bureau of Labor Statistics threw our way. They're saying home health and personal care aides will...
Continue Reading
Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....
Continue Reading
DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...
Continue Reading
The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...
Continue Reading
Top 5 Most Recently Viewed Articles
Craneware Plc Disclosure Overview Craneware Plc has recently disclosed significant details regarding its share ownership and position disclosures, primarily emphasizing the stakes held by Rathbones Group Plc, which commands a notable presence in the market. Such disclosures are crucial within the context of the UK’s takeover regulations, particularly Rule 8 of the...
Continue Reading
60 Degrees Pharmaceuticals Announces Public Offering Details 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW), a dedicated pharmaceutical company, has made a significant announcement regarding its latest public offering aimed at funding its mission to develop innovative medicines for infectious diseases. This offering, which represents an important step in expanding...
Continue Reading
LifeMD Unveils Quarterly Dividend for Preferred Stockholders LifeMD, Inc. (Nasdaq: LFMD), a top-tier provider in virtual primary care services, has officially proclaimed that its Board of Directors has approved a cash dividend for holders of the company’s Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP). This dividend is set at an attractive $0.5546875 per...
Continue Reading
Understanding Microsoft's Market Performance In today's swiftly evolving business landscape, having a clear grasp of a company's standing can significantly benefit investors and enthusiasts alike. This analysis focuses on Microsoft (NASDAQ: MSFT) and its positioning within the competitive software industry. By examining various financial metrics and growth potentials, we...
Continue Reading
Understanding FuboTV's Short Interest FuboTV's short percent of float has recently seen an increase of 3.67%. This statistic indicates that the company has a substantial 43.41 million shares sold short, which accounts for approximately 12.99% of all shares that are publicly available for trading. Notably, the current trading environment suggests it would take around 4.19...
Continue Reading